文献速递肿瘤 PET/CT

18F-FDG PET或PET/CT鉴别胸腺上皮肿瘤组织学类型的诊断准确性:一项Meta分析

Diagnostic Test Accuracy of 18F-FDG PET or PET/CT for Characterization of Histologic Type of Thymic Epithelial Tumor: A Meta-analysis.
PubMed 文献 · Clin Nucl Med · 2022-01-01

该系统评价与Meta分析检索PubMed、Cochrane和EMBASE数据库至2020年8月31日,评估18F-FDG PET或PET/CT鉴别胸腺上皮肿瘤组织学类型的诊断性能。区分胸腺癌与胸腺瘤的合并敏感度为0.89(95%CI 0.80-0.95)、特异度为0.77(95%CI 0.63-0.87);鉴别低危与高危胸腺上皮肿瘤的合并敏感度为0.90(95%CI 0.75-0.96)、特异度为0.81(95%CI 0.68-0.89)。结论认为18F-FDG PET或PET/CT对胸腺上皮肿瘤的组织学特征判定具有优良的诊断性能,但仍需大型多中心研究进一步确立其准确性。

要点

  • 区分胸腺癌与胸腺瘤:18F-FDG PET或PET/CT合并敏感度0.89、特异度0.77。
  • 鉴别低危与高危胸腺上皮肿瘤:合并敏感度0.90、特异度0.81。
  • Meta回归分析未发现研究异质性的来源变量。

核心结论

  • 18F-FDG PET或PET/CT对胸腺上皮肿瘤的组织学特征判定具有优良的诊断性能。
  • 仍需进一步大型多中心研究以确立18F-FDG PET或PET/CT鉴别胸腺上皮肿瘤组织学类型的诊断准确性。

研究设计与样本

  • 系统评价与Meta分析,检索PubMed、Cochrane数据库和EMBASE数据库,检索范围自各库最早收录日期至2020年8月31日。
  • 纳入评估18F-FDG PET或PET/CT对胸腺上皮肿瘤诊断性能的研究,计算敏感度、特异度、阳性与阴性似然比,并构建汇总受试者工作特征曲线。

主要发现

  • 区分胸腺癌与胸腺瘤:18F-FDG PET或PET/CT合并敏感度0.89(95%CI 0.80-0.95),合并特异度0.77(95%CI 0.63-0.87)。
  • 区分胸腺癌与胸腺瘤:总体阳性似然比3.9,阴性似然比0.14,合并诊断比值比28(95%CI 13-63)。
  • 鉴别低危与高危胸腺上皮肿瘤:合并敏感度0.90(95%CI 0.75-0.96),合并特异度0.81(95%CI 0.68-0.89)。
  • 鉴别低危与高危胸腺上皮肿瘤:阳性似然比4.7,阴性似然比0.12,合并诊断比值比38(95%CI 12-121)。
  • Meta回归分析中未发现任何变量是研究异质性的来源。

关键数值与推荐

  • 区分胸腺癌与胸腺瘤:合并敏感度0.89(95%CI 0.80-0.95),合并特异度0.77(95%CI 0.63-0.87),阳性似然比3.9,阴性似然比0.14,诊断比值比28(95%CI 13-63)。
  • 鉴别低危与高危胸腺上皮肿瘤:合并敏感度0.90(95%CI 0.75-0.96),合并特异度0.81(95%CI 0.68-0.89),阳性似然比4.7,阴性似然比0.12,诊断比值比38(95%CI 12-121)。

临床怎么用

  • 对于胸腺上皮肿瘤患者,可依据18F-FDG PET或PET/CT的代谢特征辅助区分胸腺癌与胸腺瘤。
  • 对于胸腺上皮肿瘤患者,可依据18F-FDG PET或PET/CT的代谢特征辅助鉴别低危与高危组织学类型。

局限性

  • 原文结论指出仍需进一步大型多中心研究以确立18F-FDG PET或PET/CT鉴别胸腺上皮肿瘤组织学类型的诊断准确性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study investigated diagnostic accuracies of 18F-FDG PET or PET/CT for characterization of histologic type of thymic epithelial tumors (TETs) through a systematic review and meta-analysis. PATIENTS AND METHODS: The PubMed, Cochrane database, and EMBASE database, from the earliest available date of indexing through August 31, 2020, were searched for studies evaluating diagnostic performance of 18F-FDG PET or PET/CT for characterization of TET. We determined the sensitivities and specificities, calculated positive and negative likelihood ratios (LR+ and LR-), and constructed summary receiver operating characteristic curves. RESULTS: The pooled sensitivity of 18F-FDG PET or PET/CT was 0.89 (95% confidence interval [CI], 0.80-0.95), and the pooled specificity was 0.77 (95% CI, 0.63-0.87) for differentiation between thymic cancer and thymoma. Likelihood ratio syntheses gave an overall positive likelihood ratio (LR+) of 3.9 and negative likelihood ratio (LR-) of 0.14. The pooled diagnostic odds ratio was 28 (95% CI, 13-63). The pooled sensitivity was 0.90 (95% CI, 0.75-0.96), and the pooled specificity was 0.81 (95% CI, 0.68-0.89) for differential diagnosis of a low-risk or high-risk TET. LR+ was 4.7 and LR- was 0.12. The pooled diagnostic odds ratio was 38 (95% CI, 12-121). In meta-regression analysis, no variable was the source of the study heterogeneity. CONCLUSIONS: 18F-FDG PET or PET/CT has excellent diagnostic performances for characterization of TET. Further large multicenter studies would be necessary to establish the diagnostic accuracy of 18F-FDG PET or PET/CT for differentiation of histologic type of TET.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Kim K, Jeong JH, Kim SJ, et al. Diagnostic Test Accuracy of 18F-FDG PET or PET/CT for Characterization of Histologic Type of Thymic Epithelial Tumor: A Meta-analysis. Clin Nucl Med. 2022. PMID: 34661556. doi:10.1097/RLU.0000000000003921

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。